The US FDA has approved denosumab (Prolia, Amgen) for treatment of glucocorticoid-induced osteoporosis. European regulators recently green-lighted the same indication.
FDA Approvals …read more
The US FDA has approved denosumab (Prolia, Amgen) for treatment of glucocorticoid-induced osteoporosis. European regulators recently green-lighted the same indication.
FDA Approvals …read more
Comments are closed.
Nice posts! 🙂
___
Sanny